SCHEMBL5043732

SCHEMBL5043732

CC(C)(C)COc1cc(C(F)(F)F)ccc1N1CCNCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.49
NCF1 P14598 1/20 0.49
ADRB1 P08588 3/20 0.46
HTR3A P46098 3/20 0.45
HTR3E A5X5Y0 2/20 0.45
HTR3B O95264 2/20 0.45
HTR3D Q70Z44 2/20 0.45
HTR3C Q8WXA8 2/20 0.45
SIGMAR1 Q99720 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HTR1D P28221 1/20 0.45
HTR2C P28335 1/20 0.45
HTR6 P50406 4/20 0.44
MAPT P10636 2/20 0.44
THRB P10828 1/20 0.44
HTR1A P08908 3/20 0.41
DRD2 P14416 1/20 0.40
CYP2C19 P33261 1/20 0.40
DRD3 P35462 1/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14015442 0.82 HTR6 (0.57) ADRB2NCF1ADRB1HTR3AHTR3E
SCHEMBL31652205 0.82 HTR6 (0.57) ADRB2NCF1ADRB1HTR3AHTR3E
SCHEMBL28042823 0.80 SLC6A4 (0.66) ADRB2NCF1ADRB1HTR3AHTR3E
SCHEMBL7821743 0.79 HTR1A (0.49) ADRB2ADRB1HTR3AHTR2CHTR6
SCHEMBL7830117 0.78 HTR1A (0.62) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL28042827 0.78 HTR6 (0.45) ADRB2NCF1ADRB1HTR3AHTR3E
SCHEMBL7821267 0.77 ADRA1D (0.46) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL6503533 0.77 ADRA1A (0.59) HTR6HTR1AADRA1DADRA1AADRA1B
SCHEMBL7821698 0.77 HTR3A (0.57) NCF1ADRB1HTR3AHTR3EHTR3B
SCHEMBL7830587 0.76 HTR3E (0.51) ADRB2NCF1ADRB1HTR3AHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319099-B2 Such as 1-{3-fluoro-4-[4-(2-isopropoxy-5-methanesulfonyl benzoyl)-piperazin-1-yl]-phenyl}-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease HOFFMANN-LA ROCHE INC. (US) 2008-01-15 US disclosed